Integrating iStent inject® Into Your Practice

Our Comprehensive Support. Your Uncompromising Patient Care.

Integrating iStent inject® and MIGS into your practice helps you expand care and provide a wider range of benefits to many of your patients. As a trusted industry leader—and the corporate founder of MIGS—we have the experience, tools, and training to make integration seamless. We lead the industry in clinical support and patient education resources, including:

  • Highly-personalized practice resources
  • In-depth training, including online modules and hands-on wet labs
  • Robust tools to help you educate patients and staff
  • Unrivaled reimbursement support

You’re Already Seeing Potential iStent inject® Patients

iStent inject® is indicated for use in adult patients with mild-to-moderate open-angle glaucoma. A review of Medicare claims data shows that approximately one in five cataract patients are also potential candidates for iStent inject®.1 By taking advantage of this one-time opportunity, you may be able to provide your patients with better IOP control and a reduced dependence on medication.

Offer Complete Treatment Options

With the rapid introduction of advanced technologies and techniques, the role of the comprehensive cataract surgeon continues to expand. Furthermore, ophthalmologists are looking for a safe and minimally invasive surgical alternative that can provide earlier intervention for mild-to-moderate open-angle glaucoma. iStent inject® provides both, enabling you to present your cataract patients with mild-to-moderate open-angle glaucoma with a complete treatment offering.

1. Data on file, Glaukos Corporation.

Looking for more information on iStent inject®?

We’re here to answer questions and provide any additional information you may need.

Contact Us